In this episode of The Innovators Podcast, host Jim Jorgenson is joined by pharmacy revenue cycle experts Maxie Friemel and Tim Miller to explore the often underestimated, and increasingly critical, world of pharmacy finances. The conversation goes well beyond billing, diving into key issues such as prior authorizations, denials, biosimilar adoption, charge structures, and payer audits.

For hospital and health system leaders, the pharmacy revenue cycle presents both significant risk and opportunity. As specialty drug costs rise and payer scrutiny intensifies, understanding pharmacy’s role in financial performance is more important than ever. Maxie and Tim share practical insights to help leaders foster collaboration across pharmacy, finance, compliance, and IT, improve charge capture, and drive clean claims.

Packed with actionable strategies and big-picture thinking, this is a must-listen episode for any hospital leader focused on strengthening financial sustainability and operational alignment.

In this episode, host Jim Jorgenson sits down with returning guest Dr. Alex Varkey to discuss big changes—both personal and professional. Since his last appearance, Alex has completed his term as President of the American Pharmacists Association (APhA) and made a major career move, leaving a successful role in health-system leadership to join Visante.

Alex shares what motivated his transition, what it’s been like stepping into the consulting world, and what lessons he’s bringing with him from his time at APhA. He also offers thoughtful advice for professionals considering a change and discusses the trends he believes will shape the next five years in pharmacy.

From workforce dynamics to innovation in care delivery, this conversation is packed with leadership insight and forward-thinking perspectives for anyone invested in the future of pharmacy.

In this episode of the Pharmacy Innovators Podcast, host Jim Jorgenson is joined by two powerhouse voices in the 340B space: Kristin Fox Smith, Visante’s own 340B expert, and Ted Slafsky, Publisher & CEO of the 340B Report.

Together, they dive into the latest political and regulatory shifts shaking the 340B landscape — from new Congressional leadership and pending legislation to the major reorganization of HHS and HRSA. The episode also explores Medicaid trends, judicial developments, contract pharmacy access, and the broader political forces shaping healthcare access for vulnerable populations.

Whether you’re a healthcare leader, policymaker, or 340B stakeholder, this episode offers timely and valuable insights into the evolving landscape of the program.

340B Report website: https://340breport.com/ Subscribe now using coupon code VISANTE25